State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$692M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Palantir
PLTR
|
+$455M |
| 4 |
Equinix
EQIX
|
+$394M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$388M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$6.29B |
| 2 |
Carrier Global
CARR
|
+$945M |
| 3 |
Otis Worldwide
OTIS
|
+$809M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$665M |
| 5 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Financials | 14.6% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
ImmunityBio
IBRX
$8.1B
| $59.9M | ﹤0.01% |
4,193,620
+1,861,048
| +80% | +$30.7M |
|
1702
CryoPort
CYRX
$762M
| $59.8M | ﹤0.01% |
948,272
+52,858
| +6% | +$2.98M |
|
1703
TTEC Holdings
TTEC
$124M
| $59.7M | ﹤0.01% |
579,085
+22,876
| +4% | +$2.38M |
|
1704
Uranium Energy
UEC
$5.57B
| $59.6M | ﹤0.01% |
22,424,963
+3,544,070
| +19% | +$10.7M |
|
|
RUBY
1705
DELISTED
Rubius Therapeutics, Inc
RUBY
| $59.6M | ﹤0.01% |
2,440,295
+1,798,409
| +280% | +$45M |
|
1706
Metallus
MTUS
$898M
| $59.6M | ﹤0.01% |
4,208,984
+2,924,530
| +228% | +$39.5M |
|
1707
Ambev
ABEV
$46.4B
| $59.5M | ﹤0.01% |
17,308,837
-1,213,401
| -7% | -$3.95M |
|
1708
Howard Hughes
HHH
$4.03B
| $59.4M | ﹤0.01% |
639,821
+124,292
| +24% | +$12.3M |
|
|
NARI
1709
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $59.4M | ﹤0.01% |
636,953
+260,372
| +69% | +$25.2M |
|
1710
Arcturus Therapeutics
ARCT
$211M
| $59.4M | ﹤0.01% |
1,755,654
+357,619
| +26% | +$12.1M |
|
1711
Knowles
KN
$3.34B
| $59.3M | ﹤0.01% |
3,003,638
+59,830
| +2% | +$1.22M |
|
|
ADAM
1712
Adamas Trust
ADAM
$883M
| $59.3M | ﹤0.01% |
3,242,934
+124,879
| +4% | +$2.27M |
|
1713
Cannae Holdings
CNNE
$649M
| $59.1M | ﹤0.01% |
1,742,487
+58,312
| +3% | +$2.17M |
|
|
WBT
1714
DELISTED
Welbilt, Inc.
WBT
| $59.1M | ﹤0.01% |
2,551,538
+63,221
| +3% | +$1.34M |
|
|
VGR
1715
DELISTED
Vector Group Ltd.
VGR
| $58.7M | ﹤0.01% |
5,849,482
+202,596
| +4% | +$2.02M |
|
|
CTEV
1716
Claritev Corp
CTEV
$556M
| $58.6M | ﹤0.01% |
153,821
+149,603
| +3,547% | +$46.3M |
|
1717
iHeartMedia
IHRT
$583M
| $58.5M | ﹤0.01% |
2,173,449
+889,154
| +69% | +$19.7M |
|
1718
Lindsay Corp
LNN
$1.18B
| $58.5M | ﹤0.01% |
353,998
+10,832
| +3% | +$1.78M |
|
1719
Spectrum Brands
SPB
$2.07B
| $58.4M | ﹤0.01% |
686,333
+111,734
| +19% | +$9.85M |
|
|
SASR
1720
DELISTED
Sandy Spring Bancorp Inc
SASR
| $58.3M | ﹤0.01% |
1,321,726
+177,734
| +16% | +$8.06M |
|
1721
Adaptive Biotechnologies
ADPT
$3.97B
| $58.3M | ﹤0.01% |
1,426,921
+473,378
| +50% | +$18.4M |
|
1722
TechTarget
TTGT
$278M
| $58.3M | ﹤0.01% |
752,409
+34,507
| +5% | +$2.48M |
|
1723
Goosehead Insurance
GSHD
$2.32B
| $58.3M | ﹤0.01% |
457,776
+149,978
| +49% | +$15.3M |
|
|
RPT
1724
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $58.2M | ﹤0.01% |
4,458,985
+53,440
| +1% | +$678K |
|
|
GRA
1725
DELISTED
W.R. Grace & Co.
GRA
| $58.1M | ﹤0.01% |
840,283
+125,786
| +18% | +$8.47M |
|
Similar funds
State Street's Q2 2021 Portfolio in Review
As of Q2 2021, State Street held 4,549 positions worth $1.9T, up 8.8% from $1.74T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q2 2021 filing shows 534 new, 2,776 increased, 937 reduced and 86 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 5,751,234 shares worth $387M. The largest sale was Alibaba, an estimated $6.29B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q2 2021 buy was Vanguard FTSE Europe ETF: 5,751,234 shares worth $387M.
- State Street added most to Blackstone in Q2 2021, an estimated $692M increase.
- State Street's biggest Q2 2021 reduction was Alibaba, cutting an estimated $6.29B.
- State Street fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $665M.
- State Street's ten largest holdings make up 21% of its $1.9T portfolio in Q2 2021.
- State Street opened 534 new positions and closed 86 in Q2 2021.
- State Street's portfolio value rose 8.8% quarter-over-quarter to $1.9T.
Based on State Street's 13F filing for Q2 2021, filed 16 Aug 2021.